DermTech Inc
General ticker "DMTK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.7M
DermTech Inc does not follow the US Stock Market performance with the rate: -27.9%.
Estimated limits based on current volatility of 4.7%: low 0.06$, high 0.09$
Factors to consider:
- Earnings expected soon, date: 2024-08-01
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 predicted range: [1.46$, 5.24$]
- 2024-12-30 to 2025-12-30 predicted range: [2.39$, 7.50$]
Financial Metrics affecting the DMTK estimates:
- Negative: Non-GAAP EPS of -3.57 <= 0.09
- Negative: Operating Income to Revenue ratio of -0.87 <= 0.01
- Negative: Operating Cash Flow per share of -2.36 <= 0.21
- Negative: negative Net Income
- Negative: Industry Operating Cash Flow per share (median) of -1.54 <= 0.29
Short-term DMTK quotes
Long-term DMTK plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $11.84MM | $14.52MM | $15.30MM |
| Operating Expenses | $89.24MM | $132.68MM | $119.03MM |
| Operating Income | $-77.40MM | $-118.17MM | $-103.74MM |
| Non-Operating Income | $-0.94MM | $1.48MM | $2.85MM |
| Interest Expense | $0.00MM | $1.34MM | $0.00MM |
| R&D Expense | $16.26MM | $24.05MM | $15.24MM |
| Income(Loss) | $-78.33MM | $-116.68MM | $-100.89MM |
| Profit(Loss) | $-78.33MM | $-116.68MM | $-100.89MM |
| Stockholders Equity | $229.70MM | $132.35MM | $57.17MM |
| Assets | $248.31MM | $202.07MM | $121.93MM |
| Operating Cash Flow | $-62.11MM | $-95.26MM | $-76.98MM |
| Investing Cash Flow | $-12.51MM | $-4.32MM | $29.86MM |
| Financing Cash Flow | $230.28MM | $0.92MM | $6.08MM |
| Earnings Per Share* | $-2.66 | $-3.79 | $-3.09 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.